147 related articles for article (PubMed ID: 1429879)
1. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J
J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879
[TBL] [Abstract][Full Text] [Related]
2. 1 alpha,25-dihydroxyvitamin D3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression.
Jenis LG; Lian JB; Stein GS; Baran DT
J Cell Biochem; 1993 Nov; 53(3):234-9. PubMed ID: 8263040
[TBL] [Abstract][Full Text] [Related]
3. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
4. Thiazide diuretics affect osteocalcin production in human osteoblasts at the transcription level without affecting vitamin D3 receptors.
Lajeunesse D; Delalandre A; Guggino SE
J Bone Miner Res; 2000 May; 15(5):894-901. PubMed ID: 10804019
[TBL] [Abstract][Full Text] [Related]
5. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
[TBL] [Abstract][Full Text] [Related]
6. 1 alpha,25-Dihydroxyvitamin D3 rapidly alters phospholipid metabolism in the nuclear envelope of osteoblasts.
Sorensen AM; Baran DT
J Cell Biochem; 1995 May; 58(1):15-21. PubMed ID: 7642719
[TBL] [Abstract][Full Text] [Related]
7. Nongenomic actions of the steroid hormone 1 alpha,25-dihydroxyvitamin D3.
Baran DT
J Cell Biochem; 1994 Nov; 56(3):303-6. PubMed ID: 7876322
[TBL] [Abstract][Full Text] [Related]
8. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
[TBL] [Abstract][Full Text] [Related]
9. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
[TBL] [Abstract][Full Text] [Related]
10. 1 alpha,25-Dihydroxyvitamin D3 rapidly increases nuclear calcium levels in rat osteosarcoma cells.
Sorensen AM; Bowman D; Baran DT
J Cell Biochem; 1993 Jun; 52(2):237-42. PubMed ID: 8396151
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3.
Mosavin R; Mellon WS
Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells.
Moreau R; Aubin R; Lapointe JY; Lajeunesse D
J Bone Miner Res; 1997 Dec; 12(12):1984-92. PubMed ID: 9421231
[TBL] [Abstract][Full Text] [Related]
13. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx.
Khoury R; Ridall AL; Norman AW; Farach-Carson MC
Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430
[TBL] [Abstract][Full Text] [Related]
14. Multiple levels of steroid hormone-dependent control of osteocalcin during osteoblast differentiation: glucocorticoid regulation of basal and vitamin D stimulated gene expression.
Shalhoub V; Aslam F; Breen E; van Wijnen A; Bortell R; Stein GS; Stein JL; Lian JB
J Cell Biochem; 1998 May; 69(2):154-68. PubMed ID: 9548563
[TBL] [Abstract][Full Text] [Related]
15. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
[TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
Subramaniam M; Colvard D; Keeting PE; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1992 Dec; 50(4):411-24. PubMed ID: 1469072
[TBL] [Abstract][Full Text] [Related]
18. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
Farach-Carson MC; Sergeev I; Norman AW
Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
[TBL] [Abstract][Full Text] [Related]
19. Binding characteristics of a membrane receptor that recognizes 1 alpha,25-dihydroxyvitamin D3 and its epimer, 1 beta,25-dihydroxyvitamin D3.
Baran DT; Ray R; Sorensen AM; Honeyman T; Holick MF
J Cell Biochem; 1994 Dec; 56(4):510-7. PubMed ID: 7890809
[TBL] [Abstract][Full Text] [Related]
20. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
